ALKS
Alkermes Plc
NASDAQ: ALKS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$33.71
-1.26% today
Updated 2026-04-29
Market cap
$5.62B
P/E ratio
23.57
P/S ratio
3.81x
EPS (TTM)
$1.43
Dividend yield
—
52W range
$25 – $36
Volume
2.4M
Alkermes Plc (ALKS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
16.40%
Operating margin
15.10%
ROE
14.70%
ROA
6.99%
Debt/equity
0.04x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $240.72M | $166.98M | 83.10% | -1.16% | 69.37% |
| 2007 | $326.84M | $130.50M | 86.72% | 41.29% | 39.93% |
| 2008 | $178.28M | $-39.63M | 72.27% | -24.14% | -22.23% |
| 2009 | $186.64M | $-45.54M | 72.04% | -24.45% | -24.40% |
| 2010 | $389.98M | $-113.68M | 67.29% | -22.64% | -29.15% |
| 2011 | $575.55M | $24.98M | 70.38% | 14.21% | 4.34% |
| 2012 | $575.55M | $24.98M | 46.06% | 14.21% | 4.34% |
| 2013 | $432.90M | $17.60M | 68.98% | 3.58% | 4.07% |
| 2014 | $618.79M | $-30.06M | 71.58% | -14.08% | -4.86% |
| 2015 | $628.34M | $-227.16M | 77.88% | -35.70% | -36.15% |
| 2016 | $745.69M | $-208.44M | 82.28% | -27.98% | -27.95% |
| 2017 | $903.37M | $-157.94M | 82.87% | -16.37% | -17.48% |
| 2018 | $1.09B | $-139.31M | 83.88% | -9.06% | -12.73% |
| 2019 | $1.17B | $-196.62M | 84.59% | -14.99% | -16.79% |
| 2020 | $1.04B | $-110.86M | 82.83% | -10.82% | -10.67% |
| 2021 | $1.17B | $-48.17M | 83.19% | 8.33% | -4.10% |
| 2022 | $1.11B | $-158.27M | 80.39% | -0.55% | -14.24% |
| 2023 | $1.66B | $355.76M | 84.79% | 24.90% | 21.39% |
| 2024 | $1.56B | $367.07M | 84.25% | 27.00% | 23.57% |
| 2025 | $1.48B | $241.66M | 86.31% | 17.21% | 16.37% |